Back to Results

A phase II study to evaluate neoadjuvant osimertinib therapy in patients with surgically resectable, EGFRmutant non-small cell lung cancer


Is this Study for You?

Let's Get Started!




II - Research Studies that gather preliminary data on whether a drug works in people who have a certain condition/disease (that is, the drug's effectiveness). For example, participants receiving the drug may be compared to similar participants receiving a different treatment, usually an inactive substance (called a placebo) or a different drug. Safety continues to be evaluated, and short-term adverse events are studied.

Type of Study



Lone Tree Medical Center
University of Colorado Hospital

Principal Investigator
Robert Doebele,  MD, PhD

Robert Doebele, MD, PhD

Study ID

Protocol Number: 19-0325

More information available at NCT03433469

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers